RIKER LAUREN (CIK 1545439) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell PCRX (6,115 shares), Sell PCRX (3,187 shares), Buy PCRX (19,273 shares), Sell PCRX (2,751 shares), Sell PCRX (4,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 6,115 | $143,702 |
| 2026-06-05 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 3,187 | $71,134 |
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Buy | 19,273 | $0 |
| 2026-02-03 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 2,751 | $56,506 |
| 2026-02-03 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 4,000 | $83,240 |
| 2026-01-06 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 159 | $3,889 |
| 2026-01-06 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 1,416 | $34,324 |
| 2025-06-05 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 3,374 | $89,074 |
| 2025-06-05 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Sell | 5,578 | $146,208 |
| 2025-02-04 | Pacira BioSciences, Inc. (PCRX) | Senior Vice President, Finance | Buy | 30,600 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12